14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for OVID

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.38 7.41 %
R2 3.31 5.04 %
R1 3.26 3.58 %
Current price: 3.15
Support S1 3.11 -1.15 %
S2 3.07 -2.61 %
S3 2.99 -4.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.43 8.89 %
R2 3.40 7.94 %
R1 3.20 1.59 %
Current price 3.15
Support S1 3.05 -3.17%
S2 2.79 -11.43%
S3 2.72 -13.65%

OVID Predictions History

4 years ago
JS predicted that OVID for 2020-04-27 is going $3.44 (-4.71%)

4 years ago
Alan predicted that OVID for 2020-04-27 is going $3.50 (2.64%)

4 years ago
ParkerWeil predicted that OVID for 2020-04-27 is going

Rank:

4 years ago
JS predicted that OVID for 2020-01-15 is going

4 years ago
Ken131740 predicted that OVID for 2020-01-15 is going

Rank:

4 years ago
2poJeff predicted that OVID for 2020-01-15 is going $3.33 (-7.50%)

4 years ago
Manuel Barbosa predicted that OVID for 2020-01-15 is going $4.00 (11.11%)

Rank:

4 years ago
JS predicted that OVID for 2020-01-03 is going $4.08 (5.15%)

4 years ago
Michael Tyler predicted that OVID for 2020-01-03 is going

4 years ago
2poJeff predicted that OVID for 2020-01-03 is going $4.22 (2.93%)

Click to get the best stock tips daily for free!

About Ovid Therapeutics Inc

Ovid Therapeutics Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule... OVID Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT